Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
Top Cited Papers
Open Access
- 27 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76 (11), 1930-1941
- https://doi.org/10.1093/cid/ciad045
Abstract
Most research on SARS-CoV-2 variants focuses on initial symptomatology with limited data on longer-term sequelae. We sought to characterize the prevalence and differences in prolonged symptoms at three months post SARS-CoV-2-infection across the three major variant time-periods (pre-Delta, Delta, and Omicron). This multicenter prospective cohort study of adults with acute illness tested for SARS-CoV-2 compared fatigue severity, fatigue symptoms, individual and organ system-based symptoms, and presence of ≥3 total symptoms across variants among COVID-positive and COVID-negative participants 3 months after their initial SARS-CoV-2 diagnosis. Variant periods were defined by dates with ≥50% dominant strain. We performed a sensitivity analysis using ≥90% dominance threshold and multivariable logistic regression modeling to estimate the independent effects of each variant adjusting for socio-demographic characteristics, baseline health, and vaccine status. The study included 3,223 participants (2,402 COVID-positive and 821 COVID-negative). Among the COVID-positive cohort, 463 (19.3%) were pre-Delta, 1,198 (49.9%) during Delta, and 741 (30.8%) during Omicron. Prolonged severe fatigue was highest in the pre-Delta COVID-positive cohort compared with Delta and Omicron cohorts (16.7% vs 11.5% vs 12.3%, respectively; p = 0.017), as was presence of ≥3 prolonged symptoms (28.4% vs 21.7% vs 16.0%; p < 0.001). No difference was seen in the COVID-negative cohort between variant time-periods. In multivariable models, there was no difference in severe fatigue between variants. There was decreased odds of having ≥3 symptoms in Omicron compared with other variants; this was not significant after adjusting for vaccination status. Prolonged symptoms following SARS-CoV-2 infection were more common among participants infected during the pre-Delta period compared with Delta and Omicron periods; however, these differences were no longer significant after adjusting for vaccination status. This suggests a potential beneficial effect of vaccination on the risk of developing long-term symptoms.Keywords
Funding Information
- National Center for Immunization and Respiratory Diseases, CDC
This publication has 30 references indexed in Scilit:
- Long COVID and Post-infective Fatigue Syndrome: A ReviewOpen Forum Infectious Diseases, 2021
- Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysisBMJ, 2021
- Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and CharacteristicsClinical Infectious Diseases, 2021
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28–180 Days After COVID-19 Diagnosis — Georgia, May 2020–March 2021Morbidity and Mortality Weekly Report (MMWR), 2021
- Sequelae in Adults at 6 Months After COVID-19 InfectionJAMA Network Open, 2021
- Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infectionPLOS ONE, 2020
- Validation of the Fatigue Severity Scale in a Swiss CohortSleep, 2008
- Chronic Fatigue Syndrome – A clinically empirical approach to its definition and studyBMC Medicine, 2005
- Psychometric properties of the CDC Symptom Inventory for assessment of Chronic Fatigue SyndromePopulation Health Metrics, 2005